Mannkind reported $54.31M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Adma Biologics ADMA:US USD 34.91M 17.51M
Biocryst Pharmaceuticals BCRX:US USD 461.19M 43.71M
Dynavax Technologies DVAX:US USD 586.49M 337.4M
Halozyme Therapeutics HALO:US USD 147.16M 56.23M
Immunogen IMGN:US USD 309.51M 64.36M
Insmed INSM:US USD 414.63M 1.44M
Jazz Pharmaceuticals JAZZ:US USD 482.67M 191.74M
Karyopharm Therapeutics KPTI:US USD 71.35M 10.9M
Macrogenics MGNX:US USD 83.99M 62.52M
Mannkind MNKD:US USD 54.31M 18.8M
Minerva Neurosciences NERV:US USD 40.22M 9.53M
Novavax NVAX:US USD 1.28B 95.01M
Peregrine Pharmaceuticals PPHM:US USD 77.29M 37.84M
Xencor XNCR:US USD 52.65M 3.24M